当前位置: X-MOL 学术Biochem. Biophys. Res. Commun. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Altered COVID-19 receptor ACE2 expression in a higher risk group for cerebrovascular disease and ischemic stroke.
Biochemical and Biophysical Research Communications ( IF 2.5 ) Pub Date : 2020-05-29 , DOI: 10.1016/j.bbrc.2020.05.203
Ji-Young Choi 1 , Hye-Kyung Lee 1 , Jung Hyun Park 1 , Sun-Jung Cho 1 , Munjin Kwon 1 , Chulman Jo 1 , Young Ho Koh 1
Affiliation  

Coronavirus disease 2019 (COVID-19) is a worldwide pandemic. It has a high transmission rate among humans, and is a threat to global public health. However, there are no effective prophylactics or therapeutics available. It is necessary to identify vulnerable and susceptible groups for adequate protection and care against this disease. Recent studies have reported that COVID-19 has angiotensin-converting enzyme 2 (ACE2) as a functional receptor, which may lead to the development of severe cerebrovascular diseases (CVD), including strokes, in patients with risk factors for CVD such as diabetes and smoking. Thus, the World Health Organization (WHO) advised caution against COVID-19 for smokers and patients with underlying clinical symptoms, including cardiovascular diseases. Here, we observed ACE2 expression in the brain of rat middle cerebral artery occlusion (MCAO) model and evaluated the effects of cigarette smoke extract (CSE) and diabetes on ACE2 expression in vessels. We showed that the levels of ACE2 expression was increased in the cortex penumbra after ischemic injuries. CSE treatment significantly elevated ACE2 expression in human brain vessels. We found that ACE2 expression was upregulated in primary cultured human blood vessels with diabetes compared to healthy controls. This study demonstrates that ACE2 expression is increased in ischemic brains and vessels exposed to diabetes or smoking, makes them vulnerable to COVID-19 infection.



中文翻译:


改变脑血管疾病和缺血性中风高危人群中的 COVID-19 受体 ACE2 表达。



2019 年冠状病毒病 (COVID-19) 是一种全球性流行病。它在人与人之间传播率很高,对全球公共卫生构成威胁。然而,没有有效的预防或治疗方法。有必要确定弱势群体和易感群体,以便对这种疾病进行充分的保护和护理。最近的研究报告称,COVID-19 具有血管紧张素转换酶 2 (ACE2) 作为功能受体,对于患有糖尿病和糖尿病等 CVD 危险因素的患者,这可能会导致严重脑血管疾病 (CVD),包括中风。吸烟。因此,世界卫生组织 (WHO) 建议吸烟者和有潜在临床症状(包括心血管疾病)的患者警惕 COVID-19。在这里,我们观察了大鼠大脑中动脉闭塞(MCAO)模型脑中ACE2的表达,并评估了香烟烟雾提取物(CSE)和糖尿病对血管中ACE2表达的影响。我们发现,缺血性损伤后皮质半影区的 ACE2 表达水平升高。 CSE 治疗显着提高了人脑血管中 ACE2 的表达。我们发现,与健康对照相比,患有糖尿病的原代培养人血管中 ACE2 表达上调。这项研究表明,在暴露于糖尿病或吸烟的缺血性大脑和血管中,ACE2 表达增加,使它们容易受到 COVID-19 感染。

更新日期:2020-05-29
down
wechat
bug